Rapid‐onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2710|40|2|125-130

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.40, Iss.2, 2015-04, pp. : 125-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression

By Rickels Karl Athanasiou Maria Reed Carol

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 217-224

Future Medicine

Access to resources Recommend Favorite

Depression in the Elderly: Pharmacologic Considerations in Treatment

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 9, 1982-09 ,pp. : 581-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intranasal ketamine shows rapid effects in depression study

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 3, 2015-03 ,pp. : 4-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A. Greist John H. Mallinckrodt Craig H. Prakash Apurva Sambunaris Angelo Tollefson Gary D. Wohlreich Madelaine M.

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

The risks and benefits of antidepressant treatment for youth depression

By Bridge Jeffrey Salary Cheryl Birmaher Boris Asare Akua Brent David

Annals of Medicine, Vol. 37, Iss. 6, 2005-10 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite